576 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 12 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x RNA tissue categoryi x
GABRQGamma-aminobutyric acid type A receptor theta subunitFDA approved drug targets
Predicted membrane proteins
Tissue enhanced
GABRR1Gamma-aminobutyric acid type A receptor rho1 subunitFDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
GABRR2Gamma-aminobutyric acid type A receptor rho2 subunitFDA approved drug targets
Predicted membrane proteins
Not detected
GABRR3Gamma-aminobutyric acid type A receptor rho3 subunit (gene/pseudogene)FDA approved drug targets
Predicted membrane proteins
Not detected
GAMTGuanidinoacetate N-methyltransferaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Group enriched
GANABGlucosidase II alpha subunitDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Nuclear membrane
Endoplasmic reticulum
Cytosol
Expressed in all
GANCGlucosidase alpha, neutral CEnzymes
FDA approved drug targets
Predicted intracellular proteins
Nucleoplasm
Actin filaments
Expressed in all
GARTPhosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Mitochondria
Cytosol
Expressed in all
GGCXGamma-glutamyl carboxylaseDisease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Expressed in all
GGPS1Geranylgeranyl diphosphate synthase 1Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
GHRHRGrowth hormone releasing hormone receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Not detected
GLRA1Glycine receptor alpha 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Not detected
GLRA2Glycine receptor alpha 2FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Group enriched
GLRA3Glycine receptor alpha 3FDA approved drug targets
Predicted membrane proteins
Transporters
Group enriched
GLRBGlycine receptor betaDisease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enhanced
GNRHRGonadotropin releasing hormone receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
GRIA1Glutamate ionotropic receptor AMPA type subunit 1FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enriched
GRIK1Glutamate ionotropic receptor kainate type subunit 1FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
GRIN1Glutamate ionotropic receptor NMDA type subunit 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Transporters
Tissue enriched
GRIN2AGlutamate ionotropic receptor NMDA type subunit 2ACancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
RAS pathway related proteins
Tissue enhanced
GRIN2BGlutamate ionotropic receptor NMDA type subunit 2BDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enriched
GRIN2CGlutamate ionotropic receptor NMDA type subunit 2CFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enhanced
GRIN2DGlutamate ionotropic receptor NMDA type subunit 2DDisease related genes
FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
GRIN3AGlutamate ionotropic receptor NMDA type subunit 3AFDA approved drug targets
Predicted membrane proteins
Group enriched
GRIN3BGlutamate ionotropic receptor NMDA type subunit 3BFDA approved drug targets
Predicted membrane proteins
Tissue enhanced
GRM5Glutamate metabotropic receptor 5FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
GSRGlutathione-disulfide reductaseCancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol
Expressed in all
GSSGlutathione synthetaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
NucleusExpressed in all
GUCY1A2Guanylate cyclase 1 soluble subunit alpha 2Enzymes
FDA approved drug targets
Predicted intracellular proteins
Tissue enhanced
GUCY2CGuanylate cyclase 2CDisease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Transporters
VesiclesGroup enriched
HBA1Hemoglobin subunit alpha 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
Group enriched
HBA2Hemoglobin subunit alpha 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
Group enriched
HBBHemoglobin subunit betaDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
VesiclesTissue enriched
HCAR2Hydroxycarboxylic acid receptor 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Cell JunctionsTissue enhanced
HCAR3Hydroxycarboxylic acid receptor 3FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Cell JunctionsTissue enhanced
HCRTR1Hypocretin receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
HCRTR2Hypocretin receptor 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Not detected
HDAC1Histone deacetylase 1Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
NucleoplasmExpressed in all
HDAC10Histone deacetylase 10Cancer-related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Nucleoli fibrillar centerMixed
HDAC11Histone deacetylase 11Enzymes
FDA approved drug targets
Predicted intracellular proteins
Mixed
HDAC2Histone deacetylase 2Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
NucleusExpressed in all
HDAC3Histone deacetylase 3Enzymes
FDA approved drug targets
Predicted intracellular proteins
Nucleoplasm
Golgi apparatus
Expressed in all
HDAC4Histone deacetylase 4Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Nucleoplasm
Cytosol
Mixed
HDAC5Histone deacetylase 5Cancer-related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Nuclear speckles
Golgi apparatus
Cytosol
Expressed in all
HDAC6Histone deacetylase 6Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
NucleoplasmExpressed in all
HDAC7Histone deacetylase 7Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
CytosolExpressed in all
HDAC8Histone deacetylase 8Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Nucleus
Plasma membrane
Expressed in all
HDAC9Histone deacetylase 9Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
NucleoplasmMixed
HMGCR3-hydroxy-3-methylglutaryl-CoA reductaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
HMMRHyaluronan mediated motility receptorCD markers
FDA approved drug targets
Predicted intracellular proteins
Microtubules
Centrosome
Cytosol
Tissue enhanced
« prev | Page of 12 | next »